Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
HER-2 L755P
Cancer:
Non Small Cell Lung Cancer
Drug:
lapatinib
(
EGFR inhibitor
,
HER2 inhibitor
)
Direction:
Resistant
Evidence:
Evidence Level:
Resistant: D – Preclinical
New
Source:
PLoS One
Title:
Differential Sensitivity of ERBB2 Kinase Domain Mutations towards Lapatinib
Excerpt:
...ERBB2-L755S (IC50>2 µM), ERBB2-L755P (IC50>1.5 µM)...caused strong lapatinib resistance.
DOI:
10.1371/journal.pone.0026760
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login